Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Smoking rate among US adults drops to record low as vape use rises, CDC report finds - 2Israeli Chief of Staff declares new border with Gaza Strip
- 3Sentimental tree to shine at Arctic League annual broadcast
- 4Study finds humans were making fire 400,000 years ago, far earlier than once thought
- 5First Alert: Light snow through this evening
- Novartis to build manufacturing hub in North Carolina, creating 700 jobs
- This Week In Space podcast: Episode 204 — A New NASA
- How to get rid of your Christmas tree — and the 1 thing to never, ever do with it
- Grasping the Elements of Medical caretaker Pay rates: Factors That Shape Your Pay
- One-third of asylum applications by Iranians approved in Germany
- Avoid Slam: Exploring the Pickup Truck Transformation
- The architect of Iran’s military survival remains defiant
- Landslides triggered by heavy rainfall kill at least 20 people in Tanzania
- Flu season is just beginning, but doctors are already on high alert
